Abstract
Abstract
OCD is characterized by obsessions and compulsions that cause distress, are time-consuming, and interfere with a patient's social, occupational, or other areas of functioning. SSRIs are first-line pharmacologic treatment options and produce response rates of up to 60% in patients with OCD. Several potential strategies have been evaluated for enhancing patient response, including high-dose SSRI therapy, antipsychotic augmentation, and memantine augmentation. Three patient cases are used to explore treatment guidelines, evaluate existing literature, and provide pharmacotherapy recommendations for the management of patients with OCD when first-line therapy fails.
Publisher
College of Psychiatric and Neurologic Pharmacists (CPNP)
Subject
Pharmacology (medical),Neurology (clinical),General Pharmacology, Toxicology and Pharmaceutics,Neuropsychology and Physiological Psychology
Reference48 articles.
1. National Institute of Mental Health [Internet].
Obsessive-compulsive disorder.
Bethesda
(MD): National Institute of Mental Health; c2022 [cited 2022 May 1]. Available from: www.nimh.nih.gov/health/statistics/obsessive-compulsive-disorder-ocd
2. American Psychiatric Association.
Diagnostic and statistical manual of mental disorders. 5th ed.
Arlington (VA):
American Psychiatric Association;2013.
3. Sadock
BJ,
Sadock
VA,
Ruiz
P.
Kaplan & Sadock's synopsis of psychiatry. 11th ed.
New York:
Wolters Kluwer;2015.
4. National Institute of Mental Health [Internet].
Statistics.
Bethesda
(MD): National Institute of Mental Health; c2022 [cited 2022 May 1]. Available from: www.nimh.nih.gov/health/statistics
5. Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder.
J Am Acad Child Adolesc Psychiatry.
2012;
51(1):
98-
113.
DOI: 10.1016/j.jaac.2011.09.019. PubMed PMID: 22176943.